Cohance Lifesciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
424.50 -20.70 (-4.65%)Updated : 15 May 2026
Fiscal Period2026202520242023
Period End DateMar 26Mar 25Mar 24Mar 23
Issuance( Retirement)of Debt Net -113.47-299.83-6.35-26.74
Net Changein Cash -47.51-41.67-17.5720.24
Cash Taxes Paid 67.77175.91109.95145.76
Net Income/ Starting Line 207.04642.63405.67559.73
Changesin Working Capital -47.01-176.64-62.54-139.99
Cashfrom Operating Activities 368.32673.35358.48457.20
Cash Interest Paid 34.1136.377.4511.56
Cashfrom Financing Activities -165.15-327.40-13.80-241.95
Issuance( Retirement)of Stock Net 32.438.80--
Depreciation/ Depletion 187.33166.8051.8146.46
Other Investing Cash Flow Items Total -34.69-72.90-310.4790.91
Capital Expenditures -219.88-316.80-51.79-285.91
period Type ----
Foreign Exchange Effects 3.892.080.000.00
Non- Cash Items 20.9640.56-36.46-9.00
Financing Cash Flow Items -84.11-36.37-7.45-11.56
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -254.57-389.70-362.25-195.01
Total Cash Dividends Paid ----203.65
*All figures in crores except per share values
Recommended For You
Trending Stocks
1,122.90+27.30(2.49%)
1,337.00-24.75 (-1.82%)
4,055.95-74.25 (-1.80%)